These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3144548)

  • 1. Rate of bactericidal activity for Branhamella catarrhalis of fleroxacin compared with that of amoxycillin-clavulanic acid.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():43-7. PubMed ID: 3144548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE; Slocombe B; White AR
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    Chemotherapy; 1988; 34(3):191-4. PubMed ID: 2843324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
    Laurans G; Gaudio F; Ducroix JP; Orfila J
    Pathol Biol (Paris); 1991 May; 39(5):391-5. PubMed ID: 1909016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the microbiology of amoxycillin/clavulanic acid over the 15 year period 1978-1993.
    Rolinson GN
    J Chemother; 1994 Oct; 6(5):283-318. PubMed ID: 7861195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis.
    Fernández-Roblas R; Jiménez Arriero M; Rodriguez-Tudela JL; Soriano F
    J Antimicrob Chemother; 1988 Dec; 22(6):867-72. PubMed ID: 3149634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin.
    Hoogkamp-Korstanje JA; Dirks-Go SI; Kabel P; Manson WL; Stobberingh EE; Vreede RW; Davies BI
    J Antimicrob Chemother; 1997 Mar; 39(3):411-4. PubMed ID: 9096192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid against Branhamella catarrhalis.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):433-4. PubMed ID: 3137055
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
    Bedenić B; Zagar Z
    J Chemother; 1994 Dec; 6(6):383-7. PubMed ID: 7699424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
    Bingen E; Bourgeois F; Chardon H; Doit C; Lambert-Zechovsky N
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):923-6. PubMed ID: 1486888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of culture medium on the comparative in-vitro activity of amoxycillin and amoxycillin/clavulanic acid against Branhamella catarrhalis.
    Soriano F; Jiménez-Arriero M; Fernández-Roblas R
    J Antimicrob Chemother; 1987 Aug; 20(2):285-6. PubMed ID: 3117763
    [No Abstract]   [Full Text] [Related]  

  • 12. Exacerbation of COPD: amoxicillin + clavulanic acid in vitro activity vs S. pneumoniae, H. influenzae and M. catarrhalis.
    Beghi G; Legnani D; De Bartolo A; Pagani N; Lusco G
    J Chemother; 1995 Nov; 7 Suppl 4():61-2. PubMed ID: 8904109
    [No Abstract]   [Full Text] [Related]  

  • 13. In-vitro bactericidal activity of four oral antibiotics against pathogens responsible for acute otitis media in children.
    Lambert-Zechovsky N; Mariani-Kurkdjian P; Doit C; Bourgeois F; Bingen E
    J Hosp Infect; 1992 Nov; 22 Suppl A():89-97. PubMed ID: 1362754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
    Doern GV; Tubert TA
    Diagn Microbiol Infect Dis; 1990; 13(4):349-52. PubMed ID: 2127558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibility of Branhamella catarrhalis to antibiotics].
    Leszczyńska K; Jakoniuk P; Sacha PT; Zalewska M; Wieczorek P
    Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
    Doern GV
    Diagn Microbiol Infect Dis; 1991; 14(1):75-7. PubMed ID: 1901536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of amoxycillin/clavulanic acid (augmentin) against beta-lactamase-positive S. aureus, H. influenzae and B. catarrhalis in an in vitro kinetic model.
    Cooper CE; Slocombe B; White AR
    J Chemother; 1989 Jul; 1(4 Suppl):350-1. PubMed ID: 16312434
    [No Abstract]   [Full Text] [Related]  

  • 18. Activity of amoxycillin-clavulanic acid against Legionella pneumophila in vitro and in an experimental respiratory infection model.
    Smith GM; Sutherland R
    J Hosp Infect; 1992 Nov; 22 Suppl A():61-7. PubMed ID: 1362751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
    Texier-Maugein J; Escoubas J; Fouche J; Mormede M
    Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR; Spangler SK; Appelbaum PC
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.